Cas:71989-23-6 Fmoc-Ile-OH manufacturer & supplier

We serve Chemical Name:Fmoc-Ile-OH CAS:71989-23-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Fmoc-Ile-OH

Chemical Name:Fmoc-Ile-OH
CAS.NO:71989-23-6
Synonyms:L-Isoleucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-isoleucine;N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-isoleucine;EINECS 276-255-9;MFCD00037125;N-(9-Fluorenylmethoxycarbonyl)-L-isoleucine;N-Fmoc-Ile-OH ( N-Fmoc-L-isoleucine);FMOC-L-Isoleucine;Fmoc-Ile-OH
Molecular Formula:C21H23NO4
Molecular Weight:353.412
HS Code:2924299090

Physical and Chemical Properties:
Melting point:145-147 °C(lit.)
Boiling point:559.8±33.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.583
PSA:75.63000
Exact Mass:353.162720
LogP:4.95

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like L-Isoleucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Fmoc-Ile-OH physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 276-255-9 Use and application,FMOC-L-Isoleucine technical grade,usp/ep/jp grade.


Related News: Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. Fmoc-Ile-OH manufacturer The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth. Fmoc-Ile-OH supplier Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. Fmoc-Ile-OH vendor Health officials said it remained unclear where he had developed the disease. Fmoc-Ile-OH factory The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.